Image
Top
Navigation

Biotech corporate branding

biotech investor branding iconDue to a change in corporate structure and new product development, created a new identity design based upon the ultrasound properties of the product (in clinical trials) that enables it to potentially correct a patient’s irregular heart rhythm via cardiac ablation.

The new branding was developed to foster investor engagement, clinical trial brand/corporate awareness globally while the product was undergoing clinical trials in Europe and the US.